Antibody-drug conjugates in the treatment of Leukemia: a constraint-satisfaction heuristic analysis of global clinical trials

Peijin Yu, Zexiang Wu

Open source

DOI
10.1016/j.tranon.2026.103098
Published
2026-12
Container
Translational Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tranon.2026.103098,
  title = {Antibody-drug conjugates in the treatment of Leukemia: a constraint-satisfaction heuristic analysis of global clinical trials},
  author = {Peijin Yu and Zexiang Wu},
  year = {2026},
  journal = {Translational Oncology},
  doi = {10.1016/j.tranon.2026.103098},
  url = {https://doi.org/10.1016/j.tranon.2026.103098}
}

RIS

TY  - JOUR
TI  - Antibody-drug conjugates in the treatment of Leukemia: a constraint-satisfaction heuristic analysis of global clinical trials
AU  - Peijin Yu
AU  - Zexiang Wu
PY  - 2026
JO  - Translational Oncology
DO  - 10.1016/j.tranon.2026.103098
UR  - https://doi.org/10.1016/j.tranon.2026.103098
ER  - 

APA

Yu, P., & Wu, Z. (2026). Antibody-drug conjugates in the treatment of Leukemia: a constraint-satisfaction heuristic analysis of global clinical trials. Translational Oncology. https://doi.org/10.1016/j.tranon.2026.103098

Source records